Showing results (341-350 of 447) with videos related to
Sort By:
Pageof 45
Chinese Journal of Cancer|January 16, 2016
Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaRui-Hua Xu, Lin Shen, Jin Li, et al.Biomolecules|September 28, 2021
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort AnalysisLiu-Fang Ye, Xiao-Meng Ji, Chao Ren, et al.Clinical and Translational Medicine|June 9, 2020
Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosisCai-Yun He, Miao-Zhen Qiu, Xin-Hua Yang, et al.The Lancet. Oncology|March 21, 2018
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trialRui-Hua Xu, Kei Muro, Satoshi Morita, et al.Cancer Medicine|March 5, 2021
The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancerZhao-Lei Zeng, Jia-Huan Lu, Yun Wang, et al.AI Zheng = Aizheng = Chinese Journal of Cancer|January 11, 2003
[Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality]Hui-qiang Huang, Wen-qi Jiang, Wei Wang, et al.Molecular Cancer|March 20, 2020
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17Kai Han, Feng-Wei Wang, Chen-Hui Cao, et al.Science Translational Medicine|January 3, 2020
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancerHuiyan Luo, Qi Zhao, Wei Wei, et al.Gut|November 13, 2024
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastasesYuanfang Li, Yongqiang Zheng, Jiaqian Huang, et al.Cancer Medicine|March 16, 2024
Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinomaMeng Xia Wei, Zheng Yang, Pan Pan Wang, et al.Pageof 45